
Jeremy Kortmansky MD
Gastrointestinal Cancer
Chief Network Officer, Smilow Cancer Hospital; Associate Professor of Clinical Medicine, Yale Cancer Center; Clinical Director, GI Medical Oncology
Join to view full profile
6 Devine StreetNorth Haven, CT 06473
Phone+1 203-407-8002
Dr. Kortmansky is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeremy Kortmansky is an oncologist based in North Haven, CT, with a subspecialty in gastrointestinal cancer. He graduated from Northwestern University's Feinberg School of Medicine in 1996 and completed his residency in Internal Medicine at Sidney Kimmel Medical College, followed by a fellowship in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center. Currently serving as Chief Network Officer at Yale New Haven Health, he has expertise in conditions such as colorectal cancer, pancreas cancer, upper GI cancer, cholangiocarcinoma and HCC. His research has been published in reputable journals, including a highly cited ASCO Guideline Update on systemic therapy for hepatocellular carcinoma. Dr. Kortmansky has received CMS Meaningful Use Stage 1 and 2 Certifications through Epic Systems Corporation.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1996 - 1999
Northwestern University The Feinberg School of MedicineClass of 1996
Certifications & Licensure
CT State Medical License 2005 - 2026
NY State Medical License 2000 - 2005
PA State Medical License 1997 - 2000
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- 2 citationsA Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer.Jingquan Jia, Ashley Moyer, Melissa Lowe, Emily Bolch, Jeremy Kortmansky
Journal of Gastrointestinal Cancer. 2024-12-09 - 6 citationsCombining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/witho...Howard S Hochster, Paul Catalano, Michelle Weitz, Edith P Mitchell, Deirdre Cohen
Journal of the National Cancer Institute. 2024-09-01 - 28 citationsPerioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.Michael Cecchini, Ronald R Salem, Marie Robert, Suzanne Czerniak, Ondrej Blaha
JAMA Oncology. 2024-08-01
Press Mentions
Smilow Cancer Hospital Care Center at Greenwich Physicians Make ‘Top Doctors’ List in ConnecticutJune 23rd, 2021
Top Docs: Smilow Cancer Hospital Care Center Guilford PhysiciansJune 23rd, 2021
Smilow Cancer Hospital Care Center at Waterford Physician Makes ‘Top Docs’ List in ConnecticutJune 23rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: